Cwa Asset Management Group, LLC Evolus, Inc. Transaction History

Cwa Asset Management Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$7.76 - $13.72 $465 - $823	-60 Reduced 0.52%	11,510 $93,000
Q4 2021 Feb 15, 2022	SELL	$5.37 - $8.38 $37,590 - $58,660	-7,000 Reduced 37.7%	11,570 $75,000
Q2 2021 Aug 03, 2021	BUY	$8.42 - $13.96 $59,234 - $98,208	7,035 Added 60.99%	18,570 $254,000
Q3 2020 Nov 13, 2020	SELL	$3.03 - $5.48 $75 - $137	-25 Reduced 0.22%	11,535 $45,000
Q1 2020 May 15, 2020	BUY	$3.53 - $12.21 $40,806 - $141,147	11,560 New	11,560 $48,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $608M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Cwa Asset Management Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Cwa Asset Management Group, LLC with notifications on news.